A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment

Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes Partnership

(2013) Paul E. Stang et al.   ANNALS OF INTERNAL MEDICINE

Commentary

(2013) Joshua J. Gagne   EPIDEMIOLOGY

Treatment Dynamics of Newly Marketed Drugs and Implications for Comparative Effectiveness Research

(2013) Joshua J. Gagne et al.   VALUE IN HEALTH

Rapid Assessment of Cardiovascular Risk Among Users of Smoking Cessation Drugs Within the US Food and Drug Administration's Mini-Sentinel Program

(2013) Sengwee Toh et al.   JAMA Internal Medicine

Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System

(2012) Sengwee Toh et al.   ARCHIVES OF INTERNAL MEDICINE

Active Safety Monitoring of Newly Marketed Medications in a Distributed Data Network: Application of a Semi-Automated Monitoring System

(2012) J J Gagne et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples

(2012) Peter M. Wahl et al.   DRUG SAFETY

Active Safety Monitoring of New Medical Products Using Electronic Healthcare Data

(2012) Joshua J. Gagne et al.   EPIDEMIOLOGY

An Event-Based Approach for Comparing the Performance of Methods for Prospective Medical Product Monitoring

(2012) Joshua J. Gagne et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Design considerations in an active medical product safety monitoring system

(2012) Joshua J. Gagne et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system

(2012) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Role of disease risk scores in comparative effectiveness research with emerging therapies

(2012) Robert J. Glynn et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Design considerations, architecture, and use of the Mini-Sentinel distributed data system

(2012) Lesley H. Curtis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Covariate Selection in High-Dimensional Propensity Score Analyses of Treatment Effects in Small Samples

(2011) Jeremy A. Rassen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development

(2011) S Schneeweiss et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A combined comorbidity score predicted mortality in elderly patients better than existing scores

(2011) Joshua J. Gagne et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Market withdrawal of new molecular entities approved in the United States from 1980 to 2009

(2011) Zaina P. Qureshi et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Applying propensity scores estimated in a full cohort to adjust for confounding in subgroup analyses

(2011) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A Maximized Sequential Probability Ratio Test for Drug and Vaccine Safety Surveillance

(2011) Martin Kulldorff et al.   Sequential Analysis-Design Methods and Applications

Privacy-Maintaining Propensity Score-Based Pooling of Multiple Databases Applied to a Study of Biologics

(2010) Jeremy A. Rassen et al.   MEDICAL CARE

Multivariate-adjusted pharmacoepidemiologic analyses of confidential information pooled from multiple health care utilization databases

(2010) Jeremy A. Rassen et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A basic study design for expedited safety signal evaluation based on electronic healthcare data

(2010) Sebastian Schneeweiss   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

(2009) Gianluca Trifirò et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY